3D Cellular Microcompartments with Hydrogel Layer for Genomic Integrity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cell culture systems experience significant genomic instability and mutation accumulation during ex vivo cell division, particularly in three-dimensional cultures, which hampers their suitability for large-scale cell therapies due to the emergence of harmful genetic and epigenetic mutations.
Innovation Solution
Development of three-dimensional cellular microcompartments comprising an external hydrogel layer and a cellular base layer, where less than 20% of cells have mutations, maintained through a specific preparation method involving cell encapsulation, apoptosis inhibitor use, and controlled culturing to preserve genomic integrity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If cells are multiplied in conventional three-dimensional culture systems to achieve industrial quantities, then cell production quantity increases, but genomic integrity deteriorates due to mutation accumulation
Solution Approach 1:
The invention divides the cell culture system into multiple independent microcompartments, each containing a limited number of cells (e.g., 1-100 cells). This segmentation prevents mutations from spreading across the entire culture and allows independent monitoring and selection of compartments with intact genomes, thereby maintaining genomic integrity while achieving large-scale production through aggregation of many small compartments.
Solution Approach 2:
The invention introduces a hydrogel matrix as an intermediary substance that encapsulates cells and provides a controlled microenvironment. This hydrogel intermediary maintains optimal physical and chemical conditions for cell proliferation while isolating cells in a way that prevents mutation spread, thus enabling both high productivity and genomic stability.
2Speed
If cells undergo numerous divisions over a short time to achieve large multiplication, then cell expansion speed increases, but mutation rate increases leading to harmful functional mutations
Solution Approach 1:
By segmenting the culture into many small microcompartments with limited cell numbers, the invention limits the maximum number of divisions any single cell lineage must undergo. This segmentation allows rapid overall expansion while preventing the accumulation of harmful mutations that would occur in large, continuous cultures requiring numerous divisions.
Solution Approach 2:
The invention implements a feedback mechanism where microcompartments are monitored for genomic integrity, and compartments showing signs of mutation or genomic instability are identified and removed from the production system. This feedback loop ensures that only healthy, genetically stable cell populations contribute to the final product, maintaining low mutation rates despite rapid expansion.
3Quantity of substance
If conventional cell culture systems are used for therapy development, then cell availability increases, but harmful mutations compromise therapeutic use
Solution Approach 1:
The invention produces therapy-ready cells by segmenting the culture into many small microcompartments, each independently monitored for genomic integrity. This approach enables the production of large quantities of cells suitable for therapy while ensuring that harmful mutations do not compromise the safety of the final therapeutic product.
Solution Approach 2:
The invention changes key cultural parameters by confining cells to microcompartments with specific size ranges (e.g., 50-500 micrometers) and controlling the cell density within each compartment. These parameter changes create an environment that supports rapid cell proliferation while maintaining genomic stability, thereby providing sufficient cell availability for therapy without the harmful mutations that plague conventional systems.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The microcompartment system effectively reduces the percentage of mutant cells to below 20%, significantly lower than conventional systems, thereby maintaining genomic stability and enabling safer use in therapeutic applications.
Implementation Method 1
comprising at least one external hydrogel layer and inside said external layer at least one layer of cells
Data Source
AI summary
The invention relates to a three-dimensional cellular microcompartment or a three-dimensional cellular microcompartment assembly comprising at least one external hydrogel layer and inside said external layer at least one layer of cells and/or at least one cellular base layer, of which less than 20% of the total population of cells present in the microcompartment or in the microcompartment assembly are cells having at least one mutation.The invention also relates to a method for producing such a microcompartment or microcompartment assembly.